Physician profile
Robert M Ward
NPI 1144309717
$74,712.60
in general payments reported to CMS, 2019-2025
8 companies · $750 in 2025
The $750 reported for 2025 was more than what 90% of Neonatal-Perinatal Medicine providers received nationally (typical 2025 total: $77.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,878 · 2020: $3,167 · 2021: $30K · 2022: $17K · 2023: $12K · 2024: $5,158 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $28.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,770.00 |
| Travel and Lodging | $28.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $48,749.00 | 2020-2025 | |
| Regeneron Pharmaceuticals, INC. | $7,000.00 | 2023 | Eylea Hd |
| Organon LLC | $4,890.00 | 2023 | |
| American Regent | $4,878.46 | 2019 | |
| Shionogi INC | $4,158.14 | 2024 | Fetroja |
| Pfizer INC. | $2,000.00 | 2019 | |
| Janssen Global Services, LLC | $1,620.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,417.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.